This month Constantia Flexibles launches its anti-counterfeit campaign aimed at tackling the global fake drug industry and ensuring consumers receive medication they can trust.


The proliferation of counterfeit drugs is a growing problem worldwide. Frau­dulently packaged medications containing fake or substandard ingredients is a US$ 200 billion industry. In fact, crimi­nals trafficking counterfeit meds make profits ten times higher than those trafficking illicit drugs. The effects on health are devastating, with around one million people dying annually due to counterfeit drugs. Brand integrity also suffers, as consumers are often unable to distinguish between imitation products and genuine medications.* 


From antibiotics to pain relievers, there are more than 500 fake versions of pharmaceutical products in circulation. Fake drugs make up between 10 to 30 percent of all medications worldwide and developing countries are hit hardest by counterfeit or substandard products. A third of counterfeit drugs contain no active ingredient at all and nearly half have either the wrong ingredients or incorrect quantities.*

Constantia Flexibles is tackling this issue head-on with its Stop Fake Drugs public awareness campaign and range of anti-counterfeiting solutions. Companies interested to find out how susceptible their packaging is to counterfeiting can even take a test on our campaign website.

Our packaging solutions offer practical support by making pharmaceuticals fake-proof, so consumers can easily recognize whether or not they’re getting the real deal. Anti-fraud elements such as security graphics, holo­grams and high-level special effects such as security pigments and inks all produce complex optical markers that are extremely difficult to reproduce.

To find out more about the counterfeit pharmaceuticals industry visit

If you would like to order our Safety Folder info sheet, simply write to stopfakedrugs(at)



* Sources: 

Ernst & Young Counterfeiting, piracy… 2013 

Ministery of Interior Pakistan, 2010

Interpol, WHO 2000